Suppr超能文献

在乳腺钼靶筛查中,既往检查对比在最终乳腺影像报告和数据系统(BI-RADS®)评估中的附加价值。

Added Value of a Previous Exam Comparison in the Final Breast Imaging and Reporting Data System (BI-RADS®) Assessment in Screening Mammography.

作者信息

De Faria Castro Fleury Eduardo, Ayres Veronica J

机构信息

Radiology, MD duFLE Diagnósticos, São Paulo, BRA.

Mastology, Faculdade de Medicina do ABC, São Paulo, BRA.

出版信息

Cureus. 2024 Oct 29;16(10):e72616. doi: 10.7759/cureus.72616. eCollection 2024 Oct.

Abstract

PURPOSE

This study aims to determine the impact of prior examination comparison in the final Breast Imaging and Reporting Data System (BI-RADS®) assessment in screening mammography. We compared the incidence of BI-RADS® categories 0, 1, 2, 3, 4, and 5 before and after comparing to the previous exam, with a focus on category 0. We also compared the radiologists' final classification according to their clinical practice experience.

MATERIALS AND METHODS

This is a prospective observational study conducted from August 2020 to February 2021. Two radiologists independently interpreted 3,896 consecutive mammograms. The final BI-RADS® category was given for the mammography blinded to the previous examinations and after comparing the previous examination. We also compared the radiologists' final classification according to their clinical practice experience.

RESULTS

A total of 3,656 patients referred for breast mammography were evaluated, and 3,531 screening mammograms were included. The final BI-RADS® classification for mammograms blinded to previous examinations was as follows: 389 (11.02%), 3,017 (85.44%), 35 (0.99%), 87 (2.46%), and 3 (0.08%) for categories 0, 1, 2, 3, 4, and 5, respectively. After comparing the previous examinations, the results were as follows: 103 (2.92%), 3,311 (93.77%), 39 (1.10%), 75 (2.12%), and 3 (0.08%) for categories 0, 1, 2, 3, 4, and 5, respectively. Reader 1 read 1,439 mammograms, while reader 2 read 2,093 mammograms. When comparing the final category of each reader independently, reader 1 classified the mammograms as 91 (7.10%), 1,181 (92.19%), two (0.16%), and seven (0.55%) for blinded mammograms and 0, 1,261 (98.44%), six (0.47%), and 14 (1.09%) for mammograms after prior examination comparison for categories 0, 1 and 2, 3 and 4, respectively. Reader 2 classified the mammograms as 194 (9.27%), 1,181 (87.52%), 27 (1.29%), and 40 (1.91%) for blinded mammograms and one (0.05%), 2,044 (97.71%), 26 (1.24%), and 21 (1.00%) for mammograms after previous exams comparison for categories 0, 1 and 2, 3, and 4, respectively.

CONCLUSION

Comparing previous mammograms of participants in breast cancer screening programs may reduce the number of BI-RADS® category 0 final classifications by 73.8% and the number of positive findings in the final classification, especially for the less experienced readers.

摘要

目的

本研究旨在确定在乳腺钼靶筛查中,先前检查对比对最终乳腺影像报告和数据系统(BI-RADS®)评估的影响。我们比较了与先前检查对比前后BI-RADS® 0、1、2、3、4和5类别的发生率,重点关注0类。我们还根据放射科医生的临床实践经验比较了他们的最终分类。

材料与方法

这是一项于2020年8月至2021年2月进行的前瞻性观察性研究。两名放射科医生独立解读了3896例连续的乳腺钼靶片。在对先前检查不知情的情况下以及在对比先前检查之后,分别给出乳腺钼靶的最终BI-RADS®类别。我们还根据放射科医生的临床实践经验比较了他们的最终分类。

结果

总共评估了3656例接受乳腺钼靶检查的患者,纳入了3531例筛查乳腺钼靶片。对先前检查不知情的乳腺钼靶片的最终BI-RADS®分类如下:0类389例(11.02%),1类3017例(85.44%),2类35例(0.99%),3类87例(2.46%),4类3例(0.08%),5类3例(0.08%)。在对比先前检查之后,结果如下:0类103例(2.92%),1类3311例(93.77%),2类39例(1.10%),3类75例(2.12%),4类3例(0.08%),5类3例(0.08%)。读者1解读了1439例乳腺钼靶片,而读者2解读了2093例乳腺钼靶片。当分别独立比较每位读者的最终类别时,读者1将对先前检查不知情的乳腺钼靶片分类为0类91例(7.10%),1类1181例(92.19%),2类2例(0.16%),3类和4类7例(0.55%);在对比先前检查之后,0类0例,1类1261例(98.44%),2类6例(0.47%),3类和4类14例(1.09%)。读者2将对先前检查不知情的乳腺钼靶片分类为0类194例(9.27%),1类1181例(87.52%),2类27例(1.29%),3类和4类40例(1.91%);在对比先前检查之后,0类1例(0.05%),1类2044例(97.71%),2类26例(1.24%),3类和4类21例(1.00%)。

结论

比较乳腺癌筛查项目参与者的先前乳腺钼靶片可能会使BI-RADS® 0类最终分类的数量减少73.8%,并减少最终分类中的阳性发现数量,尤其是对于经验较少的读者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536a/11608398/e3cfffaf0094/cureus-0016-00000072616-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验